[TNF-alpha secretion by peritoneal macrophages in endometriosis]
Observational
OA: closed
CC0
⤵ 20 in-corpus citations
AI-generated summary
This study found significantly higher TNF-alpha concentrations in peritoneal fluid of endometriosis patients, correlating with disease severity.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Beside of other cytokines and growth-factors Tumor Necrosis Factor Alpha (TNF-alpha) exerts as a macrophage-derived cytotoxic product a variety of immunologic effects in the human organism. It is also an important angiogenetic factor and regarding its cytotoxicity toward gametes TNF-alpha plays an essential role as pelvine mediator of sterility. The purpose of our study was to evaluate the TNF-alpha-synthesis of Peritoneal-Macrophages (PM) in patients with and without endometriosis and to determine if a correlation exists between TNF-alpha-synthesis and various degrees of the activity of endometriosis. For reasons of sterility 40 women underwent diagnostic laparoscopy and were staged according to the rAFS-classification as well as the macroscopic aspect of activity into a control group with endometriosis-free pelvic situs (n = 14) and three subgroups characterized by the increasing stage of the disease (n = 26). The TNF-alpha-concentrations (median) in the control group were 3.3 pg/ml, in group 2 with stage I/II rAFS and only low active endometriosis 60.2 pg/ml, in group 3 with stage I/II rAFS but high active endometriosis 83.2 pg/ml and in group 3 with stage III/IV rAFS 168 pg/ml. These data were statistically high significant and showed good conformity with the histological findings. We found significant higher TNF-alpha-concentrations in the peritoneal fluid of patients with endometriosis than in the peritoneal fluid of healthy women. There is a correlation between TNF-alpha-concentrations and the degree of disease.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (20)
- Decreased Innate Migration of Pro-Inflammatory M1 Macrophages through the Mesothelial Membrane Is Affected by Ceramide Kinase and Ceramide 1-P 2022
- Immunopathogenesis of endometriosis: An overview of the role of innate and adaptive immune cells and their mediators 2022
- O inibidor Btk Ibrutinib limita o desenvolvimento da endometriose em camundongos 2021
- Effects of Gallic Acid and Its Derivates on Inflammatory Regulation of Endometriotic Primary Cultures: Study on NF-kB mRNA Expression and IL-6 Secretion 2018
- Immunology of endometriosis 2018
- Fas-Related Apoptosis of Peritoneal Fluid Macrophages in Endometriosis Patients: Understanding the Disease 2017
- C-reactive protein of serum and peritoneal fluid in endometriosis 2012
- Efeitos do sistema intra-uterino de Levonorgestrel sobre marcadores de risco cardiovascular de pacientes com endometriose: estudo comparativo com o análogo do GnRH 2009
- Evaluation of the effect of pentoxifylline on white blood cell count in serum and peritoneal fluid in female rats with endometriosis 2008
- Genetic variation in tumour necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample 2007
- Endometriose und Inflammation 2007
- Is endometriosis associated with systemic subclinical inflammation? 2006
- Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? 2006
- Endometriosis: epidemiology and aetiological factors 2004
- Deficient expression of tumor necrosis factor receptor type 2 in the endometrium of women with endometriosis 2003
- Differentialdiagnose und Behandlungsstrategien bei Endometriose: Was tun - wann? 2003
- Endometriosis is sustained by tumour necrosis factor-alpha 2002
- Therapie der Endometriose unter Berücksichtigung der Aktivitätsgrade 2002
- Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis 2002
- Increased insulin-like growth factor 1 activity can rescue KLE endometrial-like cells from apoptosis 2001
Source provenance
- europepmc
- last seen: 2026-10-20T06:13:28.455750+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T22:00:41.816812+00:00
License: CC0
· commercial use OK